MDM2 inhibition in liposarcoma: a step in the right direction

被引：13

作者：

Constantinidou, Anastasia ^{[1
]}

Pollack, Seth M. ^{[2
,3
]}

Jones, Robin L. ^{[2
,3
]}

机构：

[1] Royal Marsden Hosp, London SW3 6JJ, England

[2] Univ Washington, Seattle, WA 98195 USA

[3] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA

来源：

LANCET ONCOLOGY | 2012年 / 13卷 / 11期

关键词：

CHEMOTHERAPY;

D O I：

10.1016/S1470-2045(12)70457-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1070 / 1071

页数：3

共 9 条

[1] Well-differentiated and dedifferentiated liposarcomas [J].

Coindre, Jean-Michel ;

Pedeutour, Florence ;

Aurias, Alain .

VIRCHOWS ARCHIV, 2010, 456 (02) :167-179

[2] Retroperitoneal liposarcomas: Follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas [J].

Fabre-Guillevin, Elizabeth ;

Coindre, Jean-Michel ;

Somerhausen, Nicolas de Saint Aubain ;

Bonichon, Francolse ;

Stoeckle, Eberhard ;

Bui, Nguyen Binh .

CANCER, 2006, 106 (12) :2725-2733

[3] Differential sensitivity of liposarcoma subtypes to chemotherapy [J].

Jones, RL ;

Fisher, C ;

Al-Muderis, O ;

Judson, IR .

EUROPEAN JOURNAL OF CANCER, 2005, 41 (18) :2853-2860

[4] Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma. [J].

Mok, Tony S. ;

Wu, Yi-Long ;

Thongprasert, Sumitra ;

Yang, Chih-Hsin ;

Chu, Da-Tong ;

Saijo, Nagahiro ;

Sunpaweravong, Patrapim ;

Han, Baohui ;

Margono, Benjamin ;

Ichinose, Yukito ;

Nishiwaki, Yutaka ;

Ohe, Yuichiro ;

Yang, Jin-Ji ;

Chewaskulyong, Busyamas ;

Jiang, Haiyi ;

Duffield, Emma L. ;

Watkins, Claire L. ;

Armour, Alison A. ;

Fukuoka, Masahiro .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (10) :947-957

[5]

Ray-Coquard I, 2012, LANCET ONCOL, P70474

[6] The cytogenetics of lipomatous tumours [J].

Rubin, BP ;

Fletcher, CDM .

HISTOPATHOLOGY, 1997, 30 (06) :507-511

[7] Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. [J].

Slamon, DJ ;

Leyland-Jones, B ;

Shak, S ;

Fuchs, H ;

Paton, V ;

Bajamonde, A ;

Fleming, T ;

Eiermann, W ;

Wolter, J ;

Pegram, M ;

Baselga, J ;

Norton, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :783-792

[8] In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 [J].

Vassilev, LT ;

Vu, BT ;

Graves, B ;

Carvajal, D ;

Podlaski, F ;

Filipovic, Z ;

Kong, N ;

Kammlott, U ;

Lukacs, C ;

Klein, C ;

Fotouhi, N ;

Liu, EA .

SCIENCE, 2004, 303 (5659) :844-848

[9] Opportunities for improving the therapeutic ratio for patients with sarcoma [J].

Wunder, Jay S. ;

Nielsen, Torsten O. ;

Maki, Robert G. ;

O'Sullivan, Brian ;

Alman, Benjamin A. .

LANCET ONCOLOGY, 2007, 8 (06) :513-524

← 1 →